Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: Application of an extended blood-brain barrier leakage correction

Journal of Magnetic Resonance Imaging

Volumn 11, Issue 5, 2000, Pages 495-505

  Haselhorst, Reta ^a   Kappos, Ludwig ^b   Bilecen, Deniz ^f   Scheffler, Klaus ^a,c   Möri, David ^b,d   Radü, Ernst W ^f   Seelig, Joachim ^a,e  

^a Biocenter and MR Ctr of the Univ   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY OF BASEL   (Switzerland)

^f NONE

Author keywords

Blood brain barrier; Cerebral blood volume; Dynamic susceptibility contrast; Multiple sclerosis; Perfusion

Indexed keywords

GADOTERIC ACID;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; GLIOSIS; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; VASODILATATION;

ADULT; BLOOD VOLUME; BLOOD-BRAIN BARRIER; BRAIN; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; FEMALE; GADOLINIUM; HETEROCYCLIC COMPOUNDS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; ORGANOMETALLIC COMPOUNDS;

EID: 0034023598     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(200005)11:5<495::AID-JMRI5>3.0.CO;2-S     Document Type: Article

References (40)

1. Lucchinetti CF, Brück W, Rodriguez M, et al.. Distinct patterns of multiple sclerosis pathology indicates hererogeneity in pathogenesis. Brain Pathol 1996;6:259-274.
2. Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3-24.
3. Brück W, Bitsch A, Kolenda H, et al. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783-793.
4. 1-weighted SE magnetic resonance images in multiple sclerosis. Neurology 1998; 50:1282-1288.
5. 1 spinecho MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1468-1476.
6. Putnam TJ. Evidences of vascular occlusion in multiple sclerosis and encephalomyelitis. Arch Neurol Neuropsychol 1935;32:1298-1321.
7. Putnam TJ. The pathogenesis of multiple sclerosis: a possible vascular factor. N Engl J Med 1933;209:786-790.
8. Wakefield AJ, More LJ, Difford J, McLaughlin JE. Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 1994;47:129-133.
9. Graham EM, Stanford MR, Sanders MD, Kasp E, Dumonde DC. A points prevalance study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol 1989;73:714-721.
10. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-265.
11. Jensen CV, Rostrup E, Blinkenberg M, Larsson HBW, Hendriksen O. Relative Regional Cerebral Blood Volume in Multiple Sclerosis. In: Proceedings of the SMR Annual Meeting, 1995. p 1297.
12. Petrella JR, Yang Y, Richert N, et al. Dynamic contrast MR measurements of relative cerebral blood volume in enhancing multiple sclerosis lesions: comparison to nonenhancing lesions and normal appearing white matter. In: Proceedings of the ISMRM Annual Meeting, 1997. p 646.
13. Lycke J, Wikkelsö C, Bergh AC, Jacobsson L, Andersen O. Regional cerebral blood flow in multiple sclerosis measured by single photon emission tomography with technetium-99m hexamethyl-propyleneamine oxime. Eur Neurol 1993;33:163-167.
14. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findigs. Radiology 1994;191:41-51.
15. Wenz F, Rempp K, Hep T, et al. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging. AJR 1996;166: 187-193.
16. Maeda M, Itoh S, Kimura H, et al. Vascularity of menigiomas and neuromas: assessment with dynamic susceptibility MR imaging. AJR 1994;163:181-186.
17. Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-299.
18. Nighoghossian N, Berthezene Y, Philippon B, et al. Hemodynamic parameter assessment with dynamic susceptibility contrast magnetic resonance imaging in unilateral symptomatic internal carotid artery occlusion. Stroke 1996;27:474-479.
19. Reith W, Heiland S, Erb G, Benner T, Forsting M, Sartor K. Dynamic contrast-enhanced T *-we)ghted MRI in pat)ents with cerebrovascular disease. Neuroradiology 1997;39:250-257.
20. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988;6:164-174.
21. Majumdar S, Gore JC. Studies of diffusion in random fields produced by variations in susceptibility. J Magn Reson 1988;78:41-55.
22. Yablonskiy D, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994;32:749-763.
23. Zierler KL. Theoretical basis of indicator-dilution methods for measuring flow and volume. Circ Res 1965;16:393-407.
24. Axel L. Cerebral blood flow determination by rapid sequence computed tomography. Radiology 1980;137:679-686.
25. Brasch RC, Bennett HF. Mechanisms of contrast enhancement for MRI. In: Contrast media in MRI, International Workshop, Berlin, 1990, Medicom.
26. Weisskoff RM, Boxerman JL, Sorensen AG, et al. Simultaneous blood volume and permeability mapping using a single Gd-based contrast injection. In: Proceedings of the SMR Annual Meeting, 1994. p 279.
27. Østergaard L, Rabinov J, Rosen BR, Gyldensted C. Simultaneous blood flow, blood volume and blood brain barrier permeability mapping using Gd-based contrast agents. In: Proceedings of the SMRM Annual Meeting, 1996. p 1307.
28. Ernst RR, Bodenhausen G, Wokaun A. Principles of nuclear magnetic resonance in one and two dimensions. Oxford: Clarendon Press; 1987.
29. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357-367.
30. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
31. Larsson HBW, Stubgaard M, Frederiksen JL, et al. Quantitation of blood-brain-barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumours. Magn Reson Med 1990;16:117-131.
32. Tofts PS, Shuter B, Pope JM. Ni-DTPA doped agarose gel - a phantom material for Gd-DTPA enhancement measurements. Magn Reson Imaging 1993;11:125-133.
33. Rempp KA, Gunnar B, Wenz F, et al. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637-641.
34. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
35. Helpap B. Leitfaden der Allgemeinen Entzüdungslehre. Berlin: Springer-Verlag; 1987.
36. Petrella JR, Grossman RI, McGowan JC, Campbell G, Cohen JA. Multiple sclerosis lesions: relationship between MR enhancement pattern and magnetization transfer effect. AJNR 1996;17:1041-1049.
37. 1H NMR relaxation times and water compartmentalization in experimental tumour models. Magn Reson Imaging 1986;4:335-342.
38. Donahue KM, Burstein D, Manning WJ, Gray ML. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn Reson Med 1994;32:66-76.
39. Shuter B, Tofts PS, Wang SC, Pope JM. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat. Magn Reson Imaging 1996;14:243-253.
40. 1 spin-echo and magnetisation transfer MR. AJNR 1998;9:675-683.